Your browser doesn't support javascript.
loading
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia.
Moles, Ernest; Howard, Christopher B; Huda, Pie; Karsa, Mawar; McCalmont, Hannah; Kimpton, Kathleen; Duly, Alastair; Chen, Yongjuan; Huang, Yizhou; Tursky, Melinda L; Ma, David; Bustamante, Sonia; Pickford, Russell; Connerty, Patrick; Omari, Sofia; Jolly, Christopher J; Joshi, Swapna; Shen, Sylvie; Pimanda, John E; Dolnikov, Alla; Cheung, Laurence C; Kotecha, Rishi S; Norris, Murray D; Haber, Michelle; de Bock, Charles E; Somers, Klaartje; Lock, Richard B; Thurecht, Kristofer J; Kavallaris, Maria.
Afiliação
  • Moles E; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney 2052, Australia.
  • Howard CB; Australian Centre for Nanomedicine, Faculty of Engineering, UNSW Sydney, Sydney 2052, Australia.
  • Huda P; School of Clinical Medicine, Medicine and Health, UNSW Sydney, Sydney 2052, Australia.
  • Karsa M; Australian Institute for Bioengineering and Nanotechnology, University of Queensland, St Lucia 4072, Australia.
  • McCalmont H; Australian Institute for Bioengineering and Nanotechnology, University of Queensland, St Lucia 4072, Australia.
  • Kimpton K; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney 2052, Australia.
  • Duly A; School of Clinical Medicine, Medicine and Health, UNSW Sydney, Sydney 2052, Australia.
  • Chen Y; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney 2052, Australia.
  • Huang Y; School of Clinical Medicine, Medicine and Health, UNSW Sydney, Sydney 2052, Australia.
  • Tursky ML; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney 2052, Australia.
  • Ma D; School of Clinical Medicine, Medicine and Health, UNSW Sydney, Sydney 2052, Australia.
  • Bustamante S; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney 2052, Australia.
  • Pickford R; School of Clinical Medicine, Medicine and Health, UNSW Sydney, Sydney 2052, Australia.
  • Connerty P; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney 2052, Australia.
  • Omari S; School of Clinical Medicine, Medicine and Health, UNSW Sydney, Sydney 2052, Australia.
  • Jolly CJ; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney 2052, Australia.
  • Joshi S; School of Clinical Medicine, Medicine and Health, UNSW Sydney, Sydney 2052, Australia.
  • Shen S; Department of Haematology and Bone Marrow Transplant, St Vincent's Hospital Sydney, Sydney 2010, Australia.
  • Pimanda JE; St Vincent's Centre for Applied Medical Research (AMR), Sydney 2010, Australia.
  • Dolnikov A; St Vincent Clinical School, Faculty of Medicine and Health, UNSW Sydney, Sydney 2052, Australia.
  • Cheung LC; Department of Haematology and Bone Marrow Transplant, St Vincent's Hospital Sydney, Sydney 2010, Australia.
  • Kotecha RS; St Vincent's Centre for Applied Medical Research (AMR), Sydney 2010, Australia.
  • Norris MD; St Vincent Clinical School, Faculty of Medicine and Health, UNSW Sydney, Sydney 2052, Australia.
  • Haber M; Bioanalytical Mass Spectrometry Facility, Mark Wainwright Analytical Centre, UNSW Sydney, Sydney 2052, Australia.
  • de Bock CE; Bioanalytical Mass Spectrometry Facility, Mark Wainwright Analytical Centre, UNSW Sydney, Sydney 2052, Australia.
  • Somers K; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney 2052, Australia.
  • Lock RB; School of Clinical Medicine, Medicine and Health, UNSW Sydney, Sydney 2052, Australia.
  • Thurecht KJ; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney 2052, Australia.
  • Kavallaris M; School of Clinical Medicine, Medicine and Health, UNSW Sydney, Sydney 2052, Australia.
Sci Transl Med ; 15(696): eabm1262, 2023 05 17.
Article em En | MEDLINE | ID: mdl-37196067
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia / Anticorpos Biespecíficos / Antineoplásicos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia / Anticorpos Biespecíficos / Antineoplásicos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article